Tenon Medical, Inc. (TNON)
NASDAQ: TNON · Real-Time Price · USD
11.41
+5.96 (109.36%)
At close: Aug 19, 2026, 4:00 PM EDT
7.85
-3.56 (-31.20%)
Pre-market: Aug 20, 2026, 7:09 AM EDT

Tenon Medical Statistics

Total Valuation

Tenon Medical has a market cap or net worth of $5.66 million. The enterprise value is $9.67 million.

Market Cap5.66M
Enterprise Value 9.67M

Important Dates

The last earnings date was Thursday, August 13, 2026, after market close.

Earnings Date Aug 13, 2026
Ex-Dividend Date n/a

Share Statistics

Tenon Medical has 496,455 shares outstanding. The number of shares has increased by 169.77% in one year.

Current Share Class 496,455
Shares Outstanding 496,455
Shares Change (YoY) +169.77%
Shares Change (QoQ) +1.88%
Owned by Insiders (%) 6.50%
Owned by Institutions (%) 5.57%
Float 450,255

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.07
Forward PS 0.88
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.82
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.58

Current Ratio 0.58
Quick Ratio 0.44
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -11.78

Financial Efficiency

Return on equity (ROE) is -551.19% and return on invested capital (ROIC) is -138.43%.

Return on Equity (ROE) -551.19%
Return on Assets (ROA) -71.98%
Return on Invested Capital (ROIC) -138.43%
Return on Capital Employed (ROCE) -749.10%
Weighted Average Cost of Capital (WACC) 13.12%
Revenue Per Employee $204,308
Profits Per Employee -$526,808
Employee Count26
Asset Turnover 0.51
Inventory Turnover 2.40

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -77.04% in the last 52 weeks. The beta is 1.40, so Tenon Medical's price volatility has been higher than the market average.

Beta (5Y) 1.40
52-Week Price Change -77.04%
50-Day Moving Average 10.51
200-Day Moving Average 25.90
Relative Strength Index (RSI) 65.24
Average Volume (20 Days) 2,665,547

Short Selling Information

The latest short interest is 223,450, so 45.01% of the outstanding shares have been sold short.

Short Interest 223,450
Short Previous Month 481,214
Short % of Shares Out 45.01%
Short % of Float 49.63%
Short Ratio (days to cover) 0.05

Income Statement

In the last 12 months, Tenon Medical had revenue of $5.31 million and -$13.70 million in losses. Loss per share was -$46.67.

Revenue5.31M
Gross Profit 3.55M
Operating Income -12.11M
Pretax Income -13.70M
Net Income -13.70M
EBITDA -11.80M
EBIT -12.11M
Loss Per Share -$46.67
Full Income Statement

Balance Sheet

The company has $1.68 million in cash and $5.68 million in debt, with a net cash position of -$4.00 million or -$8.06 per share.

Cash & Cash Equivalents 1.68M
Total Debt 5.68M
Net Cash -4.00M
Net Cash Per Share -$8.06
Equity (Book Value) -1.74M
Book Value Per Share -14.57
Working Capital -3.50M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$11.77 million and capital expenditures -$1.06 million, giving a free cash flow of -$12.83 million.

Operating Cash Flow -11.77M
Capital Expenditures -1.06M
Depreciation & Amortization 315,000
Net Borrowing 4.30M
Free Cash Flow -12.83M
FCF Per Share -$25.83
Full Cash Flow Statement

Margins

Gross margin is 66.81%, with operating and profit margins of -228.03% and -257.85%.

Gross Margin 66.81%
Operating Margin -228.03%
Pretax Margin -257.85%
Profit Margin -257.85%
EBITDA Margin -222.10%
EBIT Margin -228.03%
FCF Margin n/a

Dividends & Yields

Tenon Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -169.77%
Shareholder Yield -169.77%
Earnings Yield -241.80%
FCF Yield -226.41%

Analyst Forecast

The average price target for Tenon Medical is $44.38, which is 288.96% higher than the current price. The consensus rating is "Buy".

Price Target $44.38
Price Target Difference 288.96%
Analyst Consensus Buy
Analyst Count 2
Revenue Growth Forecast (3Y) 71.81%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on August 10, 2026. It was a reverse split with a ratio of 1:35.

Last Split Date Aug 10, 2026
Split Type Reverse
Split Ratio 1:35

Scores

Altman Z-Score n/a
Piotroski F-Score 3